デフォルト表紙
市場調査レポート
商品コード
1291475

いびき防止治療市場世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Anti-Snoring Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
いびき防止治療市場世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要:

いびき防止治療の世界市場規模は、2022年に15億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に9%の成長率(CAGR)を示し、2028年までに25億米ドルに達すると予測しています。

いびきとは、鼻や口から聞こえるうるさい呼吸音のことで、喉の軟部組織の振動によって引き起こされます。いびきは、手術やCPAP(Continuous Positive Airway Pressure:持続陽圧呼吸療法)により治療されますが、この場合、マスクを鼻や口に装着し、鼻孔に一定の空気流を供給する機械に接続されます。また、体重の維持、鼻閉の解消、睡眠姿勢の変更、アルコールや鎮静剤の摂取を控えるなど、生活習慣の改善によっても治すことができます。

いびき防止治療の市場動向:

いびき防止治療をサポートする機器の技術的進歩の高まりは、市場にプラスの影響を与える主要な要因の1つです。さらに、長期のいびきは、疲労、心臓発作、高血圧、脳卒中、2型糖尿病、血中酸素濃度の低下などの発症リスクを高めます。さらに、大きないびきや頻繁ないびきは睡眠時無呼吸症候群の兆候の1つであり、睡眠中の浅い呼吸や呼吸の休止を特徴とする慢性的な症状です。この症状は、緑内障、がん、認知・行動障害につながる可能性があります。また、睡眠時無呼吸症候群の人は、運転体力に影響を及ぼすため、自動車事故の脅威が高まります。その結果、いびきを治療するためのいびき防止アプリ、行動療法、歯科用デバイス、舌安定化デバイス(TSD)、顎前進デバイス(JAD)としても知られる下顎前進デバイス(MAD)の使用量が増加し、市場の成長を後押ししています。さらに、座りがちなライフスタイル、不健康な食生活、タバコやアルコール消費の増加、大衆の間での睡眠障害の有病率の上昇などの要因が、市場に明るい展望をもたらすと予測されています。

本レポートで回答した主な質問

  • 世界のいびき防止治療市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • COVID-19は世界のいびき防止治療市場にどのような影響を与えたか?
  • 主要な地域市場とは?
  • デバイスタイプに基づく市場の内訳は?
  • 流通チャネルに基づく市場の内訳は?
  • 業界のバリューチェーンにおける様々なステージは何か?
  • 業界における主要な促進要因と課題は何か?
  • 世界のいびき防止治療市場の構造と主要企業は?
  • 業界における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 いびき防止治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 デバイスタイプ別市場内訳

  • 下顎前突装置(MAD)
    • 市場動向
    • 市場予測
  • 舌安定化デバイス(TSD)
    • 市場動向
    • 市場予測
  • 持続陽圧呼吸器(CPAP)デバイス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 流通チャネル別市場内訳

  • 病院内薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Airway Management Inc.
    • Apnea Sciences Corporation
    • Fisher & Paykel Healthcare Corporation Limited
    • Koninklijke Philips N.V.
    • MEDiTAS Ltd.
    • Medtronic plc
    • Mitsui Chemicals Inc.
    • ResMed Inc.
    • Rotech Healthcare Inc.
    • SomnoMed
    • The Pure Sleep Company
    • Tomed GmbH
図表

List of Figures

  • Figure 1: Global: Anti-Snoring Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-Snoring Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Anti-Snoring Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Anti-Snoring Treatment Market: Breakup by Device Type (in %), 2022
  • Figure 5: Global: Anti-Snoring Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Anti-Snoring Treatment Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Anti-Snoring Treatment (Mandibular Advancement Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Anti-Snoring Treatment (Mandibular Advancement Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Anti-Snoring Treatment (Tongue Stabilizing Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Anti-Snoring Treatment (Tongue Stabilizing Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Anti-Snoring Treatment (Continuous Positive Airway Pressure (CPAP) Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Anti-Snoring Treatment (Continuous Positive Airway Pressure (CPAP) Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Anti-Snoring Treatment (Other Device Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Anti-Snoring Treatment (Other Device Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Anti-Snoring Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Anti-Snoring Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Anti-Snoring Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Anti-Snoring Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Anti-Snoring Treatment (Online) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Anti-Snoring Treatment (Online) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Anti-Snoring Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Anti-Snoring Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: North America: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: North America: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: United States: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: United States: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Canada: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Canada: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Asia-Pacific: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Asia-Pacific: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: China: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: China: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Japan: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Japan: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: India: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: India: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: South Korea: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: South Korea: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Australia: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Australia: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Indonesia: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Indonesia: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Others: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Others: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Europe: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Europe: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Germany: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Germany: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: France: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: France: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: United Kingdom: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: United Kingdom: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Italy: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Italy: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Spain: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Spain: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Russia: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Russia: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Latin America: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Latin America: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Brazil: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Brazil: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Mexico: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Mexico: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Middle East and Africa: Anti-Snoring Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Middle East and Africa: Anti-Snoring Treatment Market: Breakup by Country (in %), 2022
  • Figure 71: Middle East and Africa: Anti-Snoring Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Global: Anti-Snoring Treatment Industry: SWOT Analysis
  • Figure 73: Global: Anti-Snoring Treatment Industry: Value Chain Analysis
  • Figure 74: Global: Anti-Snoring Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-Snoring Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Anti-Snoring Treatment Market Forecast: Breakup by Device Type (in Million US$), 2023-2028
  • Table 3: Global: Anti-Snoring Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Anti-Snoring Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Anti-Snoring Treatment Market: Competitive Structure
  • Table 6: Global: Anti-Snoring Treatment Market: Key Players
目次
Product Code: SR112023A5887

Market Overview:

The global anti-snoring treatment market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.

Snoring refers to a noisy breathing sound coming through the nose or mouth of an individual, which is caused by the vibration of the soft tissues of the throat. It is medically treated using surgery or continuous positive airway pressure (CPAP), wherein a mask is worn over the nose or mouth and attached to a machine for delivering a constant flow of air into the nostrils. It can also be cured via lifestyle changes, such as maintaining body weight, relieving the nasal obstruction, changing sleep positions, and avoiding alcohol and sedating medications. 

Anti-Snoring Treatment Market Trends:

Rising technological advancements in devices that support anti-snoring treatment represent one of the key factors positively influencing the market. Moreover, long-term snoring increases the risk of developing fatigue, heart attacks, hypertension, stroke, type 2 diabetes, and decreased blood oxygen levels. Besides this, loud and frequent snoring is one of the signs of sleep apnea, which is a chronic condition characterized by shallow breaths or pauses in breathing during sleep. This condition can lead to glaucoma, cancer, and cognitive and behavioral disorders. In addition, people with sleep apnea have an increased threat of motor vehicle accidents as it can affect driving fitness. Consequently, there is a rise in the usage of anti-snoring apps, behavioral therapies, dental devices, tongue stabilizing devices (TSD), and mandibular advancing devices (MAD), also known as jaw advancing devices (JAD), to treat snoring, which is fueling the market growth. Furthermore, factors like sedentary lifestyles, unhealthy dietary habits, increasing tobacco and alcohol consumption, and the rising prevalence of sleep disorders among the masses are projected to create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-snoring treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device type and distribution channel.

Breakup by Device Type:

  • Mandibular Advancement Devices (MAD)
  • Tongue Stabilizing Devices (TSD)
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Airway Management Inc., Apnea Sciences Corporation, Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., MEDiTAS Ltd., Medtronic plc, Mitsui Chemicals Inc., ResMed Inc., Rotech Healthcare Inc., SomnoMed, The Pure Sleep Company and Tomed GmbH.

Key Questions Answered in This Report:

  • How has the global anti-snoring treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global anti-snoring treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anti-snoring treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-Snoring Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Mandibular Advancement Devices (MAD)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Tongue Stabilizing Devices (TSD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Continuous Positive Airway Pressure (CPAP) Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Airway Management Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Apnea Sciences Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Fisher & Paykel Healthcare Corporation Limited
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Koninklijke Philips N.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 MEDiTAS Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Medtronic plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Mitsui Chemicals Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 ResMed Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Rotech Healthcare Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 SomnoMed
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 The Pure Sleep Company
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Tomed GmbH
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio